Booster vaccines may be needed for ‘years to come’, says Pfizer
December 8, 2021Research and Development
Ben Osborn, country manager for Pfizer in the UK, has shared that coronavirus booster jabs will likely be necessary “for …
WHO reject convalescent plasma treatment for COVID-19
December 7, 2021Manufacturing and Production
WHO now strongly recommend against the use of convalescent plasma in the treatment of COVID-19 patients regardless of their stage …
Study reveals young people recover quickly from rare COVID-19 side effect
December 7, 2021Manufacturing and Production
Most young people under the age of 21 who develop suspected COVID-19 myocarditis (inflammation of the muscle), show mild symptoms …
GSK antibody treatment effective against Omicron, study suggests
December 7, 2021Manufacturing and Production
GlaxoSmithKline Plc have shared that research shows its antibody treatment is effective against the range of mutations in the recently-emerged …
Acadia Pharmaceuticals achieve positive Phase III results in Rett Syndrome trial
December 7, 2021Manufacturing and Production
Acadia Pharmaceuticals have announced positive top-line results from the pivotal, Phase III Lavender study, which evaluated the efficacy and safety …
Maintaining product authenticity: The solution to a serial problem
December 6, 2021Sales and Marketing
Counterfeit medicines pose a serious risk to public safety, and, in some cases, can lead to serious adverse effects (SAE) …
Sidelined or streamlined? Diabetic care and COVID-19
December 6, 2021Sales and Marketing
The worldwide restrictions put in place as a result of COVID-19 have necessitated innovation in multiple medical spheres. Diabetes, which …
TIB Molbiol develops test kits for Omicron variant detection
December 6, 2021Sales and Marketing
TIB Molbiol, a newly acquired subsidiary of Roche, has developed three new VirSNiP test kits for the detection of mutations …
FDA grants Lilly’s COVID-19 antibody therapy EUA for paediatric use
December 6, 2021Sales and Marketing
Eli Lilly has been granted an expanded Emergency Use Authorisation (EUA) for its neutralising antibody treatment, based on the safety …
J&J COVID-19 booster shows increase in antibody and T-cell responses, in Phase II trial
December 6, 2021Sales and Marketing
Johnson & Johnson have announced positive results from an independent Phase II study, which reveal that a booster shot of …
Omicron could become dominant variant in UK within weeks, expert warns
December 6, 2021Research and Development
Infectious diseases expert, Professor Paul Hunter, has warned that Omicron could become the UK’s dominant COVID-19 variant within weeks.The UK …
UK study shows Pfizer and Moderna jabs give best COVID-19 protection
December 3, 2021Medical Communications
The Pfizer and Moderna booster vaccines have been shown to provide the best overall boost response, according to a UK …
WHO say Delta measures will help fight Omicron
December 3, 2021Medical Communications
WHO officials have shared that COVID-19 health measures taken prior to the emergence of Omicron will also help combat the …
Researchers develop blood test for HPV-associated head and neck cancer
December 3, 2021Medical Communications
A new blood test developed by researchers at Mass Eye and Ear and Mass General Hospital have developed a more …
ARASENS Phase III trial for prostate cancer treatment meets primary endpoint
December 3, 2021Medical Communications
Orion and Bayer’s Phase III ARASENS trial has demonstrated an increase in overall survival, evaluating darolutamide in combination with docetaxel …
QIAGEN announces CE marking of T-cell response measuring device
December 2, 2021Business Services
QIAGEN has launched a CE-marked version of its QuantiFEROn SARS-CoV-2 assay, which measures T-cell responses to SARS-CoV-2, and aids in …
UK regulator approves antibody drug which may help tackle Omicron
December 2, 2021Research and Development
UK drug regulators have approved Xevudy (sotrovimab), a new coronavirus antibody treatment made by GlaxoSmithKline (GSK), which has been found …
EU bring forward launch of COVID-19 vaccine for children
December 1, 2021Research and Development
The rollout of Pfizer and BioNTech’s COVID-19 vaccine version for children aged five to 11 years old will begin on …
UK Health Secretary Javid urges for more COVID-19 tests amid rising Omicron cases and vaccine developments
December 1, 2021Research and Development
Health secretary of the UK, Sajid Javid, has urged the public to take lateral flow tests before attending parties this …
FDA approves new drug for identification of ovarian cancer
November 30, 2021Manufacturing and Production
The FDA announced the approval of pafolacianine, marketed as Cytalux, a new drug which could help doctors detect ovarian cancer …
Latest content
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
